Dr Emma Hayhurst will be presenting the latest data from Llusern’s work in developing fast and accurate point-of-care UTI testing technology at ECCMID23 in Copenhagen.

She’ll be talking on Sunday 16th April from 12:15 to 13:15 as part of the diagnostics session in the ‘Pipeline Corner’ in Arena 1 along with other start-up businesses who all share a desire to change the way infections are diagnosed.

More details on the speakers and the ECCMID congress can be found here: https://tinyurl.com/aud82mz4

The Lodestar DX analyser and testing system is registered with the European Patent Office (European Patent Application no: 22732302.9) and the US Patent and Trademark Office (no.18/558,490).